Body composition and nutritional status in malignant pleural mesothelioma: implications for activity levels and quality of life.


Journal

European journal of clinical nutrition
ISSN: 1476-5640
Titre abrégé: Eur J Clin Nutr
Pays: England
ID NLM: 8804070

Informations de publication

Date de publication:
10 2019
Historique:
received: 22 11 2018
accepted: 20 02 2019
revised: 17 02 2019
pubmed: 20 3 2019
medline: 8 8 2020
entrez: 20 3 2019
Statut: ppublish

Résumé

Malignant pleural mesothelioma (MPM) is an incurable cancer and optimizing daily physical activity and quality of life are key goals of patient management. Little is known about the prevalence of pre-sarcopenia and malnutrition in MPM or their associations with patient outcomes. This study aimed to determine the prevalence of pre-sarcopenia and malnutrition in MPM and investigate if activity levels and quality of life differed according to body composition and nutritional status. Patients with a diagnosis of MPM were recruited. Pre-sarcopenia was defined as low appendicular skeletal muscle mass (≤ 7.26 kg/m Sixty-one people participated (79% male, median age 69 [IQR 62-74] years and median BMI 25.8 [IQR 24.3-28.4] kg/m Participants with MPM had high rates of pre-sarcopenia and malnutrition. Pre-sarcopenia was associated with poorer activity levels, whilst malnutrition was associated with poorer quality of life. Interventions that aim to address reduced muscle mass and weight loss, should be tested in MPM to assess their impact on patient outcomes.

Sections du résumé

BACKGROUND/OBJECTIVES
Malignant pleural mesothelioma (MPM) is an incurable cancer and optimizing daily physical activity and quality of life are key goals of patient management. Little is known about the prevalence of pre-sarcopenia and malnutrition in MPM or their associations with patient outcomes. This study aimed to determine the prevalence of pre-sarcopenia and malnutrition in MPM and investigate if activity levels and quality of life differed according to body composition and nutritional status.
SUBJECTS/METHODS
Patients with a diagnosis of MPM were recruited. Pre-sarcopenia was defined as low appendicular skeletal muscle mass (≤ 7.26 kg/m
RESULTS
Sixty-one people participated (79% male, median age 69 [IQR 62-74] years and median BMI 25.8 [IQR 24.3-28.4] kg/m
CONCLUSION
Participants with MPM had high rates of pre-sarcopenia and malnutrition. Pre-sarcopenia was associated with poorer activity levels, whilst malnutrition was associated with poorer quality of life. Interventions that aim to address reduced muscle mass and weight loss, should be tested in MPM to assess their impact on patient outcomes.

Identifiants

pubmed: 30886321
doi: 10.1038/s41430-019-0418-9
pii: 10.1038/s41430-019-0418-9
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1412-1421

Auteurs

Emily Jeffery (E)

Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.
School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.

Y C Gary Lee (YCG)

Respiratory Department, Sir Charles Gairdner Hospital, Nedlands, WA, 6009, Australia.
Institute for Respiratory Health, Nedlands, WA, 6009, Australia.
Medical School, University of Western Australia, Crawley, WA, Australia.

Robert U Newton (RU)

Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.
School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.
School of Human Movement and Nutrition Sciences, University of Queensland, St Lucia, QLD, Australia.

Philippa Lyons-Wall (P)

School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.

Joanne McVeigh (J)

School of Occupational Therapy, Speech Therapy and Social Work, Curtin University, Perth, WA, Australia.
Movement Physiology Laboratory, School of Physiology, University of Witwatersrand, Johannesburg, 2000, South Africa.

Anna K Nowak (AK)

Medical School, University of Western Australia, Crawley, WA, Australia.
Medical Oncology Department, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
National Centre for Asbestos Related Diseases, University of Western Australia, Crawley, WA, Australia.

Hui Min Cheah (HM)

Medical School, University of Western Australia, Crawley, WA, Australia.

Bella Nguyen (B)

Medical Oncology Department, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

Deirdre B Fitzgerald (DB)

Respiratory Department, Sir Charles Gairdner Hospital, Nedlands, WA, 6009, Australia.

Jenette Creaney (J)

Institute for Respiratory Health, Nedlands, WA, 6009, Australia.
Medical School, University of Western Australia, Crawley, WA, Australia.
National Centre for Asbestos Related Diseases, University of Western Australia, Crawley, WA, Australia.

Leon Straker (L)

School of Physiotherapy and Exercise Science, Curtin University, Perth, WA, Australia.

Carolyn J Peddle-McIntyre (CJ)

Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia. c.mcintyre@ecu.edu.au.
School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia. c.mcintyre@ecu.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH